import { capitalize } from "@/lib/utils";

const columns = [
  { name: "Jistota", uid: "confidence", sortable: true },
  { name: "ID Záznamu", uid: "ic_amb_zad", sortable: true },
  { name: "ID Karty", uid: "ic_amb_karta", sortable: true },
  { name: "ID Pacienta", uid: "ic_pac", sortable: true },
  { name: "Datum zadání", uid: "dat_zad", sortable: true },
  { name: "Čas zadání", uid: "cas_zad", sortable: true },
  { name: "ID Doktora", uid: "prac_od" },
  { name: "Typ", uid: "type" },
  { name: "DG_KOD", uid: "dg_kod" },
  { name: "Terapie", uid: "text_dg" },
  { name: "Kód diagnózy", uid: "i_dg_kod" },
  { name: "Název diagnozy", uid: "i_text_dg" },
  { name: "Poznámka", uid: "poz_text" },
  { name: "Text záznamu", uid: "amb_zaz_text" },
  { name: "Možnosti", uid: "actions" },
];

const records = [
  {
    confidence: ".19028929027621827031",
    ic_amb_zad: "26607512",
    ic_amb_karta: "6059137",
    ic_pac: "86335",
    dat_zad: "2023-05-31",
    cas_zad: "12:47:00",
    prac_od: "41742",
    dg_kod: "",
    i_dg_kod: "C911 ",
    text_dg: "kontrola, CLL akcelerace ",
    i_text_dg: "Chronick\u00e1 lymfocytick\u00e1 leukemie z B-bun\u011bk ",
    poz_text: "",
    amb_zaz_text:
      "Odb\u011br:31.05.2023 10:40 WBC 15.42 10^9/l RBC 4.67 10^12/l HGB 136 g/l HCT 0.41 l/l MCV 87.4 fL PLT 122 10^9/l MCH 29.1 pg MCHC 333 g/l MPV 10.2 fl RDW 13.2 % NEU% 19.4 % LYM% 77.3 % MON% 2.7 % EOS% 0.3 % BAS% 0.3 % NEU 3 10^9/l LYM 11.92 10^9/l MONO 0.42 10^9/l EOS 0.04 10^9/l BASO 0.04 10^9/l dnes ob\u011bry pouze KO, biochemie neodebr\u00e1na * projekt CLL akcelerace 31/5/2023 posledn\u00ed odb\u011br po restartu terapie * sono b\u0159icha 14.9.2021 v\u00fdrazn\u00e1 splemomegalie, dilatovan\u00e1 lien\u00e1ln\u00ed \u017e\u00edla a port\u00e1ln\u00ed \u017e\u00edla, 14x7cm, st.p. CHCE ledviny v norm\u011b meteorismus, j\u00e1tgran nezv\u011bt\u0161ena jemn\u011b zrnit\u00e9 struktury, bez lo\u017eiskov\u00fdch zm\u011bn * 12.4.23 sono b\u0159icha: j\u00e1tra nezvt\u0161en\u00e1, zrnit\u00e9 struktury, bez lo\u017eiskov\u00fdch zm\u011bn, st.p. CHCE v portae p\u0159etrvf\u00e1v\u00e1 dialtovan\u00e1 17mm, lewin\u00e1ln\u00ed \u017e\u00edla 14-17mm slezina 197x67x48mm, ojedin\u011bl\u00e9 kalcifikace zrnit\u00e1 struktura ledviny v norm\u011b, septovan\u00e1 korov\u00e1\u00fd cysta 51mm vlevo, progrese velikosti od minule, bez lithi\u00e1zy 27.4.23 p\u0159etrv\u00e1v\u00e1 splenomegalie s dilatovanou lien\u00e1ln\u00ed \u017e\u00edlou i port\u00e1ln\u00ed \u017e\u00edlou, obraz je stacion\u00e1rn\u00ed septovan\u00e1 cysta lev\u00e9 ledviny s progres\u00ed velkosti, chornick\u00e1 nefropatie st.p. CHCE subj c\u00edt\u00ed se dob\u0159e, r\u00e1na po trh\u00e1n\u00ed zub\u016f zhojena, od 17/5/2023 znovu u\u017e\u00edv\u00e1 ibrutinib, nem\u00e1 krv\u00e1cen\u00ed, nem\u00e1 B symptomy obj: ECOG 0, 72kg ob\u011bhov\u011b komp, j\u00e1tra nezv\u011bt\u0161ena, slezina +5cm pod oblouk, ale pravd\u011bpodobn\u011b ji\u017e bylo p\u0159edt\u00edm (4/2023 splenomegalie vs sek. p\u0159i port\u00e1ln\u00ed hypertenzi) b\u0159icho je m\u011bkk\u00e9, bez rezistence, bez ascitu dkk bez otok\u016f Lu p\u0159ed k\u00fdva\u010dem vlevo 2x2cm, jinak nehmat\u00e1m ve v\u0161ech lokalizac\u00edch Dg Porucha vyprazdnov\u00e1n\u00ed mo\u010dov\u00e9ho m\u011bch\u00fd\u0159e, septovan\u00e1 cysta lev\u00e9 ledviny s progres\u00ed velikosti, urologicky sledov\u00e1na Extrakce zub\u016f 5.5.23 - p\u0159eru\u0161en ibrutinib, do medikace zp\u011bt zaveden 17/5/2023 Chronick\u00e1 lymfatick\u00e1 leuk\u00e9mie, datum dg nen\u00ed uvedeno, 1.7.21 poprv\u00e9 na IHOK, vstupn\u00ed stadium neuvedeno - p\u0159ed 30 lety terapie kortikoidy a leukeran 1990? DR Peprla sledoval r\u016fzn\u011b - mutovan\u00fd IgVGH, v\u00fdrazn\u00e1 splenoemgalie k pupku, Rai IV A - paraprotein\u00e9mie Ig G kappa, stabiln\u00ed 6g/l, hypogamaglobulin\u00e9mie IgM, IgA - sonografie 16.12.2020 22x12x8 cm velikost sleziny - 1.7.21 : mutace p53, mut IGHVodb\u011br prognostick\u00fdch fakotr\u016f n\u00edzce komplexn\u00ed karyotyp - pacientka napl\u0148uje krit\u00e9ria S\u00daKL zah\u00e1jen\u00ed l\u00e9\u010dby BCR inhibitorem - imbruvica start dne 12/8/2021 v 1. linii l\u00e9\u010dby - 26.8.2021 progrese trombocytopenie zat\u00edm pokra\u010duje Imbruvica stejn\u011b - dosa\u017eeno parci\u00e1ln\u00ed remise - 23.6..22 parci\u00e1ln\u00ed remise, Rai IVA, vysok\u00e9 riziko nemoci, nad\u00e1le lehk\u00e1 tromobcytopenie nov\u011b m\u00edrn\u00e1 neutropenie - imbruvica pora\u010duje stejn\u011b - p\u0159i progresi neutropenie SP k vyolu\u010den\u00ed MDS - 28.7.22 parci\u00e1ln\u00ed remise, pokra\u010dujeme Rai IA - p\u0159eru\u0161ena imbruvica 31.8.22 pro frakturu tibie, 19.9.22 nen \u00edprogrese Rai OA, - 24.10.22 p\u0159eru\u0161ena imbruvic,a sejmut\u00ed ort\u00e9zy 25.10. dle v\u00fdsledku RTG - 7.11.2022 Rai OA, indikov\u00e1no restart imbruvica - parci\u00e1ln\u00ed remise, 27.3.2023 Rai OA, terapie imbruvica - p\u0159eru\u0161ena imbruvica pro pl\u00e1n extrakce zub\u016f od 27.4.23 kontroal po extrakci tento t\u00fdden 11.5.23, pokud bude zhojeno, tedy restart imbruvica od 17.5.23 Dle sonografie 12.4.23 a 27.4.23 splneomgalie, nelze vylou\u010dit port\u00e1ln\u00ed hypertenzi diltace porty a lien\u00e1ln\u00ed \u017e\u00edly od r 2021 Pseudohyperkal\u00e9mie - p\u0159i leukocyt\u00f3ze Chronick\u00e1 ren\u00e1ln\u00ed insuficience, kreatinin 92 GF 0,85 Cysta lev\u00e9 ledviny dle sonografie, sledov\u00e1j\u00ed DM 2. typu na PAD, o\u010dek\u00e1v\u00e1na glykosurioe p\u0159i gliflozinu Hypertenze Alergie propolis Doporu\u010den\u00ed: Prenesa 4mg 1x, Vokanamet 50/1000mg 2x1 hematologick\u00e1 medikace: Imbruvica 140mg 3-0-0 znovu od 17/5/2023 - P\u0159i u\u017e\u00edv\u00e1n\u00ed Imbruvicy je nutn\u00e9 vynechat konzumaci grapefruit\u016f a t\u0159ezalky. - Imbruvica m\u016f\u017ee v\u00e9st k poru\u0161e funkce krevn\u00edch desti\u010dek, proto je nutn\u00e9 tento l\u00e9k p\u0159ed jak\u00fdmkoliv krv\u00e1civ\u00fdm v\u00fdkonem vysadit 5-7 p\u0159ed v\u00fdkonem a nasadit zp\u011bt do medikace 5-7 dn\u00ed po v\u00fdkonu - Nen\u00ed vhodn\u00e9 sou\u010dasn\u00e9 pod\u00e1v\u00e1n\u00ed antikoagula\u010dn\u00ed terapie warfarinem. Pokud je nutno nasadit LMWH/heparin nebo DOAC, terapie Imbruvicou se mus\u00ed p\u0159echodn\u011b p\u0159eru\u0161it a jej\u00ed op\u011btovn\u00e9 nasazen\u00ed je nutn\u00e9 zkonzultovat s na\u0161\u00edm centrem. - Imbruvica je metabolizov\u00e1na CYP3A4, p\u0159ed nasazen\u00edm l\u00e9k\u016f ovliv\u0148uj\u00edc\u00edch funkci tohoto enzymu je nutn\u00e1 konzultace s n\u00e1mi a event. \u00faprava d\u00e1vky Imbruvicy - makrolidy, ciprofloxacin, azolov\u00e1 antimykotika, n\u011bkter\u00e1 antivirotika, diltiazem, verapamil, amiodaron, n\u011bkter\u00e1 antiepileptika. - mezi nej\u010dast\u011bj\u0161\u00ed ne\u017e\u00e1douc\u00ed \u00fa\u010dinky imbruvicy pat\u0159\u00ed krv\u00e1civ\u00e9 komplikace, fibrilace s\u00edn\u00ed a pr\u016fjem - tyto pot\u00ed\u017ee vhodn\u00e9 s n\u00e1mi konzultovat * dnes rcp. 3 balen\u00ed Imbruvica 140mg \u00e1 90ks Odb\u011bry: KO+diff+ret, ZBV, Pokud nebudou nov\u00e9 pot\u00ed\u017ee, pak kontrola u n\u00e1s v z\u00e1\u0159\u00ed, op\u011bt odb\u011bry cestou amb 8 a pot\u00e9 vy\u0161et\u0159en\u00ed u Dr. Brychtov\u00e9, 6. patro pavilon L, amb 13 Dal\u0161\u00ed kontrola v 8 dne: 06.09.2023 11:00 ",
  },
  {
    confidence: ".18964225079414553931",
    ic_amb_zad: "27089330",
    ic_amb_karta: "6059137",
    ic_pac: "86335",
    dat_zad: "2023-11-22",
    cas_zad: "12:57:00",
    prac_od: "41742",
    dg_kod: "",
    i_dg_kod: "C911 ",
    text_dg: "imbruvica ",
    i_text_dg: "Chronick\u00e1 lymfocytick\u00e1 leukemie z B-bun\u011bk ",
    poz_text: "",
    amb_zaz_text:
      "dnes odb\u011br serolgolie hepatitid, za\u00edtm nejsou v\u00fdsledky Odb\u011br:22.11.2023 11:36 ------------------------------------------------------------ Ret% 1.37 % Reta 65.20 10^9/l IRF 0.071 RET-He 34.7 pg WBC 12.510 10^9/l RBC 4.76 10^12/l HGB 142.0 g/l HCT 0.430 l/l MCV 89.3 fL PLT 98.0 10^9/l MCH 29.8 pg MCHC 334.0 g/l MPV 10.40 fl RDW 13.1 % NEU% 26.60 % LYM% 69.40 % MON% 3.40 % EOS% 0.40 % BAS% 0.20 % NEU 3.330 10^9/l LYM 8.680 10^9/l MONO 0.430 10^9/l EOS 0.050 10^9/l BASO 0.020 10^9/l NRBC 0.02 * sono b\u0159icha 14.9.2021 v\u00fdrazn\u00e1 splemomegalie, dilatovan\u00e1 lien\u00e1ln\u00ed \u017e\u00edla a port\u00e1ln\u00ed \u017e\u00edla, 14x7cm, st.p. CHCE ledviny v norm\u011b meteorismus, j\u00e1tgran nezv\u011bt\u0161ena jemn\u011b zrnit\u00e9 struktury, bez lo\u017eiskov\u00fdch zm\u011bn * 12.4.23 sono b\u0159icha: j\u00e1tra nezvt\u0161en\u00e1, zrnit\u00e9 struktury, bez lo\u017eiskov\u00fdch zm\u011bn, st.p. CHCE v portae p\u0159etrvf\u00e1v\u00e1 dialtovan\u00e1 17mm, lewin\u00e1ln\u00ed \u017e\u00edla 14-17mm slezina 197x67x48mm, ojedin\u011bl\u00e9 kalcifikace zrnit\u00e1 struktura ledviny v norm\u011b, septovan\u00e1 korov\u00e1 cysta 51mm vlevo, progrese velikosti od minule, bez lithi\u00e1zy 16.8.2023 sono b\u0159icha: j\u00e1tra norm\u00e1ln \u00edvelioti a norm\u00e1ln \u00edechogenity, bez lo\u017eiskov\u00fdch ztm\u011bn, intrahepatick\u00e9 \u017elu\u010dovody nejosu dilatovgn,m jatenr\u00ed \u017e\u00edly bez dilatace, pankreas homogenn\u00ed,bez lo\u017eiskov\u00fdch z\u011bmn, bez dilatace duktu, slezina 18x5,3cm, splenomegalie, septovan\u00e1 cysta lev\u00e9 ledviny,k dilatace port\u00e1ln\u00ed a lien\u00e1ln\u00ed \u017e\u00edly, bez progrese, st.p. CHCE CT 17.10.2023 struma nodosa vpravo, GGO vlevo S 1/2 zvt\u011b\u0161en \u00e1slezina j\u00e1tra dle CT varikozn\u011b zm\u011bn\u011bn\u00e1 vena lienalis, zv\u011bt\u0161en\u00e1 slezina, cysty ledvin a cysta vkevi B II myomatozn\u00ed uterus ----------------------------------------------------------- subj c\u00edt\u00ed se dob\u0159e na urologii nechod\u00ed, d\u0159\u00edve chodila do Surgalu, nev\u00ed kdy asi letos na endokrinologii se \u0161t\u00edtnou \u017el\u00e1zou nechod\u00ed nem\u00e1 krv\u00e1cen\u00ed, nem\u00e1 B symptomy obj: ECOG 0, 72kg ob\u011bhov\u011b komp, b\u0159icho m\u011bkk\u00e9 j\u00e1tra nezv\u011bt\u0161ena, slezina +5cm pod oblouk dlouhodob b\u0159icho je m\u011bkk\u00e9, bez rezistence, bez ascitu dkk bez otok\u016f Lu nejsou hamtn\u00e9 ve v\u0161ech lokaliza\u00edch ani na krku Dg Chronick\u00e1 lymfatick\u00e1 leuk\u00e9mie, datum dg nen\u00ed uvedeno, 1.7.21 poprv\u00e9 na IHOK, vstupn\u00ed stadium neuvedeno - p\u0159ed 30 lety terapie kortikoidy a leukeran 1990? DR Peprla sledoval r\u016fzn\u011b - mutovan\u00fd IgVGH, v\u00fdrazn\u00e1 splenoemgalie k pupku, Rai IV A - paraprotein\u00e9mie Ig G kappa, stabiln\u00ed 6g/l, hypogamaglobulin\u00e9mie IgM, IgA - sonografie 16.12.2020 22x12x8 cm velikost sleziny - 1.7.21 : mutace p53, mut IGHVodb\u011br prognostick\u00fdch fakotr\u016f n\u00edzce komplexn\u00ed karyotyp - pacientka napl\u0148uje krit\u00e9ria S\u00daKL zah\u00e1jen\u00ed l\u00e9\u010dby BCR inhibitorem - imbruvica start dne 12/8/2021 v 1. linii l\u00e9\u010dby - 26.8.2021 progrese trombocytopenie zat\u00edm pokra\u010duje Imbruvica stejn\u011b - dosa\u017eeno parci\u00e1ln\u00ed remise - 23.6..22 parci\u00e1ln\u00ed remise, Rai IVA, vysok\u00e9 riziko nemoci, nad\u00e1le lehk\u00e1 tromobcytopenie nov\u011b m\u00edrn\u00e1 neutropenie - imbruvica pora\u010duje stejn\u011b - p\u0159i progresi neutropenie SP k vyolu\u010den\u00ed MDS - 28.7.22 parci\u00e1ln\u00ed remise, pokra\u010dujeme Rai IA - p\u0159eru\u0161ena imbruvica 31.8.22 pro frakturu tibie, 19.9.22 nen \u00edprogrese Rai OA, - 24.10.22 p\u0159eru\u0161ena imbruvica sejmut\u00ed ort\u00e9zy 25.10. dle v\u00fdsledku RTG - 7.11.2022 Rai OA, indikov\u00e1no restart imbruvica - parci\u00e1ln\u00ed remise, 27.3.2023 Rai OA, terapie imbruvica - p\u0159eru\u0161ena imbruvica pro pl\u00e1n extrakce zub\u016f od 27.4.23 kontrola po extrakci tento t\u00fdden 11.5.23, restart imbruvica od 17.5.23 - 6.9.23 trv\u00e1 parci\u00e1ln\u00ed remise, dle CT 17.10.2023 bez detekce lymfadeenopatie - 22.11.2023 paric\u00e1ln\u00ed remise, pokra\u010dujeme Elevace AST nejasn\u00e9 eitologie 6.9.23 - 1.7.2021 serologiue hepatitid negativn\u00ed, CMV Ig G pzitivn\u00ed, Ig M negativn\u00ed Splenomegalie, hepatomegalie, v. poarte roz\u0161\u00eden\u00e1 20mm, v lienalis je varikozn\u00ed \u0161\u00ed\u0159e 15mm dle CT 17.10.2023 - port\u00e1ln\u00ed hypertenze nejasn\u00e9 etiologie - Zrnit\u00e1 struktura jater dle sonografie 12.4.23 a 27.4.23 - splenomegalie, nelze vylou\u010dit port\u00e1ln\u00ed hypertenzi dilatace porty a lien\u00e1ln\u00ed \u017e\u00edly od r 2021 - jatern\u00ed cirhoza ? Porucha vyprazdnov\u00e1n\u00ed mo\u010dov\u00e9ho m\u011bch\u00fd\u0159e, septovan\u00e1 cysta lev\u00e9 ledviny s progres\u00ed velikosti, - saonograficky mo\u010dov\u00fd m\u011bch\u00fd\u00e1\u0159 pr\u00e1zdn\u00fd, urologick\u00e1 kontrola dr Kr\u00e1l\u00edk, Surgal, zpr\u00e1vu nem\u00e1, jewn sonografii Struma nodosa, objedn\u00e1na na endokrinoloigii leden 2024 Pseudohyperkal\u00e9mie - p\u0159i leukocyt\u00f3ze Chronick\u00e1 ren\u00e1ln\u00ed insuficience, kreatinin 92 GF 0,85 - t.\u010d. v norm\u011b Cysta lev\u00e9 ledviny dle sonografie, sledov\u00e1n\u00ed na urol\u016fgii DM 2. typu na PAD, o\u010dek\u00e1v\u00e1na glykosurioe p\u0159i gliflozinu Hypertenze Alergie propolis Doporu\u010den\u00ed: pan\u00ed je pou\u010dena o port\u00e1ln\u00ed hypertenzi a o onemocnn\u011bn\u00ed jater, vzhelem k port\u00e1ln\u00ed hypertenzi je vhodn\u00e9 do\u0161et\u0159it etiologii jatern\u00edho posti\u017een\u00ed a ev doplnit gastrofibroskopii, sp\u00e1dov\u011b gastroenterologie nemocnice U sv. Anny, Peka\u0159sk\u00e1, p\u0159ed\u00e1v\u00e1m \u017e\u00e1danku, pan\u00ed je pou\u010dena Prenesa 4mg 1x, Invokana 100mg 1x Vokanamet 50/1000mg vysazen hematologick\u00e1 medikace: Imbruvica 140mg 3-0-0 - P\u0159i u\u017e\u00edv\u00e1n\u00ed Imbruvicy je nutn\u00e9 vynechat konzumaci grapefruit\u016f a t\u0159ezalky. - Imbruvica m\u016f\u017ee v\u00e9st k poru\u0161e funkce krevn\u00edch desti\u010dek, proto je nutn\u00e9 tento l\u00e9k p\u0159ed jak\u00fdmkoliv krv\u00e1civ\u00fdm v\u00fdkonem vysadit 5-7 p\u0159ed v\u00fdkonem a nasadit zp\u011bt do medikace 5-7 dn\u00ed po v\u00fdkonu - Nen\u00ed vhodn\u00e9 sou\u010dasn\u00e9 pod\u00e1v\u00e1n\u00ed antikoagula\u010dn\u00ed terapie warfarinem. Pokud je nutno nasadit LMWH/heparin nebo DOAC, terapie Imbruvicou se mus\u00ed p\u0159echodn\u011b p\u0159eru\u0161it a jej\u00ed op\u011btovn\u00e9 nasazen\u00ed je nutn\u00e9 zkonzultovat s na\u0161\u00edm centrem. - Imbruvica je metabolizov\u00e1na CYP3A4, p\u0159ed nasazen\u00edm l\u00e9k\u016f ovliv\u0148uj\u00edc\u00edch funkci tohoto enzymu je nutn\u00e1 konzultace s n\u00e1mi a event. \u00faprava d\u00e1vky Imbruvicy - makrolidy, ciprofloxacin, azolov\u00e1 antimykotika, n\u011bkter\u00e1 antivirotika, diltiazem, verapamil, amiodaron, n\u011bkter\u00e1 antiepileptika. - mezi nej\u010dast\u011bj\u0161\u00ed ne\u017e\u00e1douc\u00ed \u00fa\u010dinky imbruvicy pat\u0159\u00ed krv\u00e1civ\u00e9 komplikace, fibrilace s\u00edn\u00ed a pr\u016fjem - tyto pot\u00ed\u017ee vhodn\u00e9 s n\u00e1mi konzultovat dnes 3 balen\u00ed imbruvica 140mg 90tbl Odb\u011bry: KO+diff+ret, ZBV, LD, CRP, CB, alb INR, APTT, fibrinogen Dal\u0161\u00ed kontrola v 8 dne: 14.02.2024 12:00 ",
  },
  {
    confidence: ".15617776094877541814",
    ic_amb_zad: "26553158",
    ic_amb_karta: "6059137",
    ic_pac: "86335",
    dat_zad: "2023-04-25",
    cas_zad: "14:13:00",
    prac_od: "41742",
    dg_kod: "",
    i_dg_kod: "C911 ",
    text_dg: "",
    i_text_dg: "Chronick\u00e1 lymfocytick\u00e1 leukemie z B-bun\u011bk ",
    poz_text: "",
    amb_zaz_text:
      ' pan\u00ed m \u00e1sono b\u017e\u0159icha a m\u00e1 v\u011bt\u0161\u00ed slezinu konrola 5.6.2023 p\u0159\u00ed\u0161t\u00ed t\u00fdden 5.5.2023 bude m\u00edt extrakci n\u011bkolika zub\u016f je pl\u00e1n p\u0159eru\u0161en \u00edimbruvica pan\u00ed p\u0159ijde z\u00edtra v 11-12hodin na odb\u011bry na amb 8 odb\u011br "CLL akcelerace" p\u0159i medikaci imruvica - 5x5ml EDTA,m \u017e\u00e1danka mol genetika CLL akcelerace + KO diff na sklo flow periferie ( viz rozpis projektu dr Panovsk\u00e1) potom domluva dr brychtov\u00e1, 6. patro dal\u0161\u00ed odb\u011bry cca 9-10.5.23 ( odb\u011br cca t\u00fdden po vysazen\u00ed) 5x5ml EDTA, KO diff na sklo dal\u0161\u00ed odb\u011bry za 14 dn\u00ed ppo restartu imbruvica ----------------------------------------------------------------- Dal\u0161\u00ed kontrola v 4 dne: 05.06.2023 11:00 ',
  },
  {
    confidence: ".11047073586410049994",
    ic_amb_zad: "26559401",
    ic_amb_karta: "6059137",
    ic_pac: "86335",
    dat_zad: "2023-05-09",
    cas_zad: "13:50:00",
    prac_od: "41742",
    dg_kod: "",
    i_dg_kod: "C911 ",
    text_dg: "odb\u011bry CLL akcelerace ",
    i_text_dg: "Chronick\u00e1 lymfocytick\u00e1 leukemie z B-bun\u011bk ",
    poz_text: "",
    amb_zaz_text:
      'Po\u010d\u00e1tek vy\u0161et\u0159en\u00ed: 09.05.2023 12:35 Odb\u011br:09.05.2023 11:49 WBC 10.870 10^9/l RBC 4.42 10^12/l HGB 131.0 g/l HCT 0.390 l/l MCV 88.7 fL PLT 127.0 10^9/l MCH 29.6 pg MCHC 334.0 g/l MPV 9.10 fl RDW 13.2 % NEU% 29.50 % LYM% 66.20 % MON% 3.70 % EOS% 0.40 % BAS% 0.20 % NEU 3.210 10^9/l LYM 7.200 10^9/l MONO 0.400 10^9/l EOS 0.040 10^9/l BASO 0.020 10^9/l NRBC 0.01 10^9/l NRBC/WBC 0.10 /100WBC MorfoLEU Hl\u00e1\u0161Anal Abnormal Lympho susp. Odb\u011br:09.05.2023 11:50 Urea S-Urea 5.9 mmol/l (2.8-8.1) Kreat. S-Kreatinin 84 umol/l (44-80) CKD-EPI CKD-EPI Krea 0.93 ml/s/1.73m2 (1-2.4) KM S-Kys.mo\u010dov\u00e1 234 umol/l (143-339) Na S-Na 131 mmol/l (136-145) K S-K 4.6 mmol/l (3.5-5.1) Cl S-Cl 96 mmol/l (98-107) Bi-celk. S-Bilirubin celk 8.8 umol/l (2-21) ALT S-ALT 0.26 ukat/l (0.25-0.58) AST S-AST 0.3 ukat/l (0.17-0.6) GGT S-GMT 0.12 ukat/l (0.1-0.7) ALP S-ALP 0.82 ukat/l (0.58-1.74) LD S-LD 2.75 ukat/l (2.25-3.55) Gluk\u00f3za S-Glukosa 7.8 mmol/l (3.9-5.6) CRP S-CRP mg/l men\u0161\u00ed ne\u017e 1.0 (0-5) KOMENTAR KOMENTAR (-) Materi\u00e1l S/P: :s\u00e9rum KOMENTAR: Pozn. \u017eadatele:odb\u011br na statim do nestatin * odb\u011br vzroku CLL akcelerace * sono b\u0159icha 14.9.2021 v\u00fdrzan\u00e1 sploegalie, dialtovan\u00e1 lein\u00e1ln\u00ed \u017e\u00edla a por\u00e1tln\u00ed \u017e\u00edla, 14x7cm, st.p. CHCE ledviny v norm\u011b meteorismus, j\u00e1tgran ezvt\u0161ena jemn\u011b zrnit\u00e9 struktury, bez lo\u017eiskov\u00fdch zm\u011bn * 12.4.23 sono b\u0159icha: j\u00e1tra nezvt\u0161en\u00e1, zrnit\u00e9 struktury, bez lo\u017eiskov\u00fdch zm\u011bn, sdt.p. CHCE v portae p\u0159etrvf\u00e1v\u00e1 dialtovan\u00e1 17mm, lewin\u00e1ln\u00ed \u017e\u00edla 14-17mm salezina 197x67x48mm, ojedin\u011bl\u00e9 kalcifikace zrnit\u00e1 struktura ledviny v norm\u011b, septovan\u00e1 korov\u00e1\u00fd cysta 51mm vlevo, progrese velikosti od minule , bez lithi\u00ed\u00e1zy 27.4.23 p\u0159etrv\u00e1v\u00e1 splenomegalie s dilatovanou lien\u00e1ln\u00ed \u017e\u00edlou i port\u00e1ln\u00ed \u017e\u00edlou,,m obraz je stacion\u00e1rn\u00ed septovan \u00e1cysta lev\u00e9 ledviny s progres\u00ed velkosti, chornick\u00e1 nefropatie st.p. CHCE subj trh\u00e1n\u00ed zub\u016f probh\u011blo 5.5.23, imburivcu m\u00e1 d\u00e1el vysazenou urolglie bude za 3 m\u011bs\u00edce ke kontrole cysty nem\u00e1 krv\u00e1cen\u00ed nem\u00e1 B symptomy obj: ECOG 0 , 72kg ob\u011bhov\u011b komp bez hmatn\u00e9 lymfadenopatie, j\u00e1tra nezv\u011bt\u0161ena, slezina nen\u00ed hmatni, b\u0159icho je m\u011bkk\u00e9, bez rezistence, bez ascitu dkk bez otok\u016f Dg Porucha vyprazdnov\u00e1n\u00ed mo\u010dov\u00e9ho m\u011bch\u00fd\u0159e,septovan \u00e1cystal ev\u00e9 ledivny s progres\u00ed velikosti - urologick\u00e9 sledov\u00e1n\u00ed Extrakce zub\u016f 5.5.23 - p\u0159eru\u0161ena imbruvica Chronick\u00e1 lymfatick\u00e1 leuk\u00e9mie, datum dg nen\u00ed uvedeno, 1.7.21 poprv\u00e9 na IHOK - vstupn\u00ed stadium neuvdeno - p\u0159ed 30 lety terapie kortikoidy a leukeran 1990? DR Peprla sledoval - r\u016fzn\u011b - mutovan\u00fd IgVGH, v\u00fdrazn\u00e1 splenoemgalie k pupku, Rai IV A - parraprotein\u00e9mie Ig G kappa, stabiln\u00ed 6g/l, hypogamaglobulin\u00e9mie Ig M, Ig A - sonografie 16.12.2020 22x12x8 cm velikost sleziny - 1.7.21 : mutace p53, mut IGHVodb\u011br prognostick\u00fdch fakotr\u016f n\u00edzce komplexn\u00ed karyotyp - pacientka napl\u0148uje krit\u00e9ria S\u00daKL zah\u00e1jen\u00ed l\u00e9\u010dby BCR inhibitorem - imbruvica start dne 12/8/2021 v 1. linii l\u00e9\u010dby - 26.8.2021 progrese trombocytopenie zat\u00edm pokra\u010duje Imbruvica stejn\u011b - dosa\u017eeno parci\u00e1ln\u00ed remise - 23.6..22 parci\u00e1ln\u00ed remise, Rai IVA, vysok\u00e9 riziko nemoci, nad\u00e1le lehk\u00e1 tromobcytopenie nov\u011b m\u00edrn\u00e1 neutropenie - imbruvica pora\u010duje stejn\u011b - p\u0159i progresi neutropenie SP k vyolu\u010den\u00ed MDS - 28.7.22 parci\u00e1ln\u00ed remise, pokra\u010dujeme Rai IA - p\u0159eru\u0161ena imbruvica 31.8.22 pro frakturu tibie, 19.9.22 nen \u00edprogrese Rai OA, - 24.10.22 p\u0159eru\u0161ena imbruvic,a sejmut\u00ed ort\u00e9zy 25.10. dle v\u00fdsledku RTG - 7.11.2022 Rai OA, indikov\u00e1no restart imbruvica - parci\u00e1ln\u00ed remise, 27.3.2023 Rai OA, terapie imbruvica - p\u0159eruena imbruvica pro pl\u00e1n extrakce zub\u016f od 27.4.23 kontroal po extrakci tento t\u00fdden 11.5.23, pokud bude zhojeno, tedy restart imbruvica od 17.5.23 dle sonografie 12.4.23 a 27.4.23 splneomgalie, nelze vylou\u010dit port\u00e1ln\u00ed hypertenzi diltace porty a lien\u00e1ln\u00ed \u017e\u00edly od r 2021 Pseudohyperkal\u00e9mie - p\u0159i leukocyt\u00f3ze Chronick\u00e1 ren\u00e1ln\u00ed insuficience, kreatinin 92 GF 0,85 Cysta lev\u00e9 ledviny dle sonografie, sledov\u00e1j\u00ed DM 2. typu na PAD, o\u010dek\u00e1v\u00e1na glykosurioe p\u0159i gliflozinu Hypertenze Alergie propolis Doporu\u010den\u00ed: p\u0159eruena imbruvica pro pl\u00e1n extrakce zub\u016f od 27.4.23 kontrola po extrakci tento t\u00fdden 11.5.23, pokud bude zhojeno, tedy restart imbruvica od 17.5.23 mediakce dlouhodob\u011b Prenesa 4mg 1x, Vokanamet 50/1000mg 2x1 hematologick\u00e1 medikace: Imbruvica 140mg nyn \u00edp\u0159er\u0161ueno - P\u0159i u\u017e\u00edv\u00e1n\u00ed Imbruvicy je nutn\u00e9 vynechat konzumaci grapefruit\u016f a t\u0159ezalky. - Imbruvica m\u016f\u017ee v\u00e9st k poru\u0161e funkce krevn\u00edch desti\u010dek, proto je nutn\u00e9 tento l\u00e9k p\u0159ed jak\u00fdmkoliv krv\u00e1civ\u00fdm v\u00fdkonem vysadit 5-7 p\u0159ed v\u00fdkonem a nasadit zp\u011bt do medikace 5-7 dn\u00ed po v\u00fdkonu - Nen\u00ed vhodn\u00e9 sou\u010dasn\u00e9 pod\u00e1v\u00e1n\u00ed antikoagula\u010dn\u00ed terapie warfarinem. Pokud je nutno nasadit LMWH/heparin nebo DOAC, terapie Imbruvicou se mus\u00ed p\u0159echodn\u011b p\u0159eru\u0161it a jej\u00ed op\u011btovn\u00e9 nasazen\u00ed je nutn\u00e9 zkonzultovat s na\u0161\u00edm centrem. - Imbruvica je metabolizov\u00e1na CYP3A4, p\u0159ed nasazen\u00edm l\u00e9k\u016f ovliv\u0148uj\u00edc\u00edch funkci tohoto enzymu je nutn\u00e1 konzultace s n\u00e1mi a event. \u00faprava d\u00e1vky Imbruvicy - makrolidy, ciprofloxacin, azolov\u00e1 antimykotika, n\u011bkter\u00e1 antivirotika, diltiazem, verapamil, amiodaron, n\u011bkter\u00e1 antiepileptika. - mezi nej\u010dast\u011bj\u0161\u00ed ne\u017e\u00e1douc\u00ed \u00fa\u010dinky imbruvicy pat\u0159\u00ed krv\u00e1civ\u00e9 komplikace, fibrilace s\u00edn\u00ed a pr\u016fjem - tyto pot\u00ed\u017ee vhodn\u00e9 s n\u00e1mi konzultovat Tel. na na\u0161\u00ed amb. 53223 3562 Odb\u011bry: KO+diff na sklo ZBV, ionty statim do nestatim zkumavky beta 2 mikrogloublin odb\u011br "CLL akcelerace" , imbruvica p\u0159eru\u0161ena dne 27.4.23 - 31.5.23 : 5x5ml EDTA,m \u017e\u00e1danka mol genetika CLL akcelerace + KO diff na sklo ( viz rozpis projektu dr Panovsk\u00e1) odb\u011bry po nasazen\u00ed medikace za 2 t\u00fddny 31.5.23 dle kontroly a po\u010dtu ibmruvica doma nap\u00ed\u0161eme dal\u0161\u00ed medikaci a objedn\u00e1me na kontorlu za 3 m\u011bs\u00edce v z\u00e1\u0159\u00ed Dal\u0161\u00ed kontrola v 8 dne: 31.05.2023 11:00 ',
  },
  {
    confidence: ".11025680107610830171",
    ic_amb_zad: "25833197",
    ic_amb_karta: "6059137",
    ic_pac: "86335",
    dat_zad: "2023-01-09",
    cas_zad: "15:09:00",
    prac_od: "41742",
    dg_kod: "",
    i_dg_kod: "C911 ",
    text_dg: "imbruvica ",
    i_text_dg: "Chronick\u00e1 lymfocytick\u00e1 leukemie z B-bun\u011bk ",
    poz_text: "",
    amb_zaz_text:
      "Odb\u011br:09.01.2023 10:54 ------------------------------------------------------------ Ret% 1.64 % Reta 72.30 10^9/l IRF 0.107 RET-He 33.2 pg WBC 19.830 10^9/l RBC 4.41 10^12/l HGB 130.0 g/l HCT 0.400 l/l MCV 89.6 fL PLT 111.0 10^9/l MCH 29.5 pg MCHC 329.0 g/l MPV 10.30 fl RDW 13.5 % NEU% 19.50 % LYM% 76.90 % MON% 2.90 % EOS% 0.40 % BAS% 0.30 % NEU 3.880 10^9/l LYM 15.250 10^9/l MONO 0.580 10^9/l EOS 0.070 10^9/l BASO 0.050 10^9/l NRBC 0.00 Odb\u011br:09.01.2023 10:54 Urea S-Urea 6.8 mmol/l (2.8-8.1) Kreat. S-Kreatinin 81 umol/l (45-84) CKD-EPI CKD-EPI Krea 0.98 ml/s/1.73m2 (1-2.4) KM S-Kys.mo\u010dov\u00e1 299 umol/l (143-339) Na S-Na 137 mmol/l (136-145) K S-K 4.4 mmol/l (3.5-5.1) Cl S-Cl 102 mmol/l (98-107) Bi-celk. S-Bilirubin celk 11.7 umol/l (2-21) ALT S-ALT 0.18 ukat/l (0.25-0.58) AST S-AST 0.28 ukat/l (0.17-0.6) GGT S-GMT 0.15 ukat/l (0.1-0.7) ALP S-ALP 0.77 ukat/l (0.58-1.74) LD S-LD 2.17 ukat/l (2.25-3.55) Gluk\u00f3za S-Glukosa 5.9 mmol/l (3.9-5.6) CRP S-CRP 1.1 mg/l (0-5) * ortopedie 25.10.22 d\u016fe RTG zhojeno, ort\u00e9za ex, berle postupn\u011b odli\u017et, n\u00e1cvik ch\u016fze, plnh\u00e1 z\u00e1\u011b\u017e za 3-4 t\u00fddny subj pan\u00ed si che br\u00e1t lah\u016fdkov\u00e9 kvasnice, d\u00e1le hl\u00edvu \u00fast\u0159i\u010dnou sanitku ji\u017e neppot\u0159ebuje nem\u00e1 B symptomy obj ECOG 0, 72kg obh\u011bov\u011b komp bez hmatn\u00e9 lymfadenopatie, j\u00e1tra nezv\u011b\u0161tena, selzina nezv\u011b\u0161tena, dkk bez otok\u016f Dg Chronick\u00e1 lymfatick\u00e1 leuk\u00e9nie, datum dg nen\u00ed uvedeno, dnes 1.7.21 poprv\u00e9 na IHOK - vstupn\u00ed stadium neuvdeno - p\u0159ed 30 lety terapie kortikoidy a leukeran 1990? DR Peprla sledoval - r\u016fzn\u011b - mutovan\u00fd IgVGH, v\u00fdrazn\u00e1 splenoemgalie k pupku, Rai IV A - parraprotein\u00e9mie Ig G kappa, stabiln\u00ed 6g/l, hypogamaglobulin\u00e9mie Ig M, Ig A - sonografie 16.12.2020 22x12x8 cm velikost sleziny - 1.7.21 : mutace p53, mut IGHVodb\u011br prognostick\u00fdch fakotr\u016f n\u00edzce komplexn\u00ed karyotyp - pacientka napl\u0148uje krit\u00e9ria S\u00daKL zah\u00e1jen\u00ed l\u00e9\u010dby BCR inhibitorem - imbruvica start dne 12/8/2021 v 1. linii l\u00e9\u010dby - 26.8.2021 progrese trombocytopenie zat\u00edm pokra\u010duje Imbruvica stejn\u011b - dosa\u017eeno parci\u00e1ln\u00ed remise - 23.6..22 parci\u00e1ln\u00ed remise, Rai IVA, vysok\u00e9 riziko nemoci, nad\u00e1le lehk\u00e1 tromobcytopenie nov\u011b m\u00edrn\u00e1 neutropenie - imbruvica pora\u010duje stejn\u011b - p\u0159i progresi neutropenie SP k vyolu\u010den\u00ed MDS - 28.7.22 parci\u00e1ln\u00ed remise, pokra\u010dujeme Rai IA - p\u0159eru\u0161ena imbruvica 31.8.22 pro frakturu tibie, 19.9.22 nen \u00edprogrese Rai OA, - 24.10.22 p\u0159eru\u0161ena imbruvic,a sejmut\u00ed ort\u00e9zy 25.10. dle v\u00fdsledku RTG - 7.11.2022 Rai OA, indikov\u00e1no restart imbruvica Pseudohyperkal\u00e9mie - p\u0159i leukocyt\u00f3ze Chronick\u00e1 ren\u00e1ln\u00ed insuficience, kreatinin 92 GF 0,85 Cysta lev\u00e9 ledviny dle sonografie, sledov\u00e1j\u00ed DM 2. typu na PAD, o\u010dek\u00e1v\u00e1na glykosurioe p\u0159i gliflozinu Hypertenze Alergie propolis Doporu\u010den\u00ed: mediakce dlouhodob\u011b Prenesa 4mg 1x, Vokanamet 50/1000mg 2x1 hematolgick\u00e1 medikace: Imbruvica 140mg 3-0-0, zap\u00edt min. 200ml vody od 8.11.22 - P\u0159i u\u017e\u00edv\u00e1n\u00ed Imbruvicy je nutn\u00e9 vynechat konzumaci grapefruit\u016f a t\u0159ezalky. - Imbruvica m\u016f\u017ee v\u00e9st k poru\u0161e funkce krevn\u00edch desti\u010dek, proto je nutn\u00e9 tento l\u00e9k p\u0159ed jak\u00fdmkoliv krv\u00e1civ\u00fdm v\u00fdkonem vysadit 5-7 p\u0159ed v\u00fdkonem a nasadit zp\u011bt do medikace 5-7 dn\u00ed po v\u00fdkonu - Nen\u00ed vhodn\u00e9 sou\u010dasn\u00e9 pod\u00e1v\u00e1n\u00ed antikoagula\u010dn\u00ed terapie warfarinem. Pokud je nutno nasadit LMWH/heparin nebo DOAC, terapie Imbruvicou se mus\u00ed p\u0159echodn\u011b p\u0159eru\u0161it a jej\u00ed op\u011btovn\u00e9 nasazen\u00ed je nutn\u00e9 zkonzultovat s na\u0161\u00edm centrem. - Imbruvica je metabolizov\u00e1na CYP3A4, p\u0159ed nasazen\u00edm l\u00e9k\u016f ovliv\u0148uj\u00edc\u00edch funkci tohoto enzymu je nutn\u00e1 konzultace s n\u00e1mi a event. \u00faprava d\u00e1vky Imbruvicy - makrolidy, ciprofloxacin, azolov\u00e1 antimykotika, n\u011bkter\u00e1 antivirotika, diltiazem, verapamil, amiodaron, n\u011bkter\u00e1 antiepileptika. - mezi nej\u010dast\u011bj\u0161\u00ed ne\u017e\u00e1douc\u00ed \u00fa\u010dinky imbruvicy pat\u0159\u00ed krv\u00e1civ\u00e9 komplikace, fibrilace s\u00edn\u00ed a pr\u016fjem - tyto pot\u00ed\u017ee vhodn\u00e9 s n\u00e1mi konzultovat ---------------------------------------------------------------- Z hlediska chronick\u00e9 paaradontitis je pl\u00e1nov\u00e1no dle doporu\u010den\u00ed stomatologaa sund\u00e1n\u00ed m\u016fstku a mnoho\u010detn\u00e9 extrakce zub\u016f Imbruvica zp\u016fsobuje trombocytopatii a tedy je nutno stejn\u011b jako anopyrin 7 dn\u00ed p\u0159ed extrakc\u00ed vysadit a nasadit a\u017e za 7 dn\u00ed. Pokud budou prov\u00e1d\u011bny mnoho\u010detn\u00e9 jednoduch\u00e9 extrakce postupn\u011b a bude doba hojen\u00ed trvat p\u016fl roku, je riziko progrese chronick\u00e9 lymfatick\u00e9 leuk\u00e9mie po vysazen\u00ed imbruvica. Je vhodn\u00e9 zv\u00e1\u017eit rychlej\u0161\u00ed proveden\u00ed extrakc\u00ed nap\u0159 ve dvou dob\u00e1ch a tedy minimalizovat dobu p\u0159eru\u0161en\u00ed protin\u00e1dorov\u00e9 terapie. Pan\u00ed je pou\u010dena Tel. na na\u0161\u00ed amb. 53223 3562 dnes 3 balen\u00ed imbruvica Odb\u011bry: KO+dif., rtc., ZBV, ionty statim do nestatim zkumavky Dal\u0161\u00ed kontrola v 8 dne: 27.03.2023 12:30 ",
  },
  {
    confidence: ".096119563039786762304",
    ic_amb_zad: "26707222",
    ic_amb_karta: "6059137",
    ic_pac: "86335",
    dat_zad: "2023-09-06",
    cas_zad: "13:31:00",
    prac_od: "41742",
    dg_kod: "",
    i_dg_kod: "C911 ",
    text_dg: "ibrutinib ",
    i_text_dg: "Chronick\u00e1 lymfocytick\u00e1 leukemie z B-bun\u011bk ",
    poz_text: "",
    amb_zaz_text:
      "Odb\u011br:06.09.2023 10:48 ------------------------------------------------------------ Ret% 2.08 % Reta 98.30 10^9/l IRF 0.082 WBC 16.400 10^9/l RBC 4.73 10^12/l HGB 144.0 g/l HCT 0.440 l/l MCV 92.2 fL PLT 135.0 10^9/l MCH 30.4 pg MCHC 329.0 g/l MPV 11.30 fl RDW 13.8 % NEU% 27.40 % LYM% 68.50 % MON% 3.66 % EOS% 0.25 % BAS% 0.20 % NEU 4.490 10^9/l LYM 11.200 10^9/l MONO 0.599 10^9/l EOS 0.042 10^9/l BASO 0.033 10^9/l NRBC 0.00 10^9/l NRBC/WBC Odb\u011br:06.09.2023 10:47 Urea S-Urea 7.5 mmol/l (2.8-8.1) Kreat. S-Kreatinin 100 umol/l (44-80) CKD-EPI CKD-EPI Krea 0.75 ml/s/1.73m2 (1-2.4) KM S-Kys.mo\u010dov\u00e1 322 umol/l (143-339) Na S-Na 138 mmol/l (136-145) K S-K 4.8 mmol/l (3.5-5.1) Cl S-Cl 101 mmol/l (98-107) Bi-celk. S-Bilirubin celk 21 umol/l (2-21) ALT S-ALT 4.23 ukat/l (0.25-0.58) AST S-AST 0.78 ukat/l (0.17-0.6) GGT S-GMT 1.68 ukat/l (0.1-0.7) ALP S-ALP 1.90 ukat/l (0.58-1.74) LD S-LD 3.07 ukat/l (2.25-3.55) Gluk\u00f3za S-Glukosa 6.5 mmol/l (3.9-5.6) CRP S-CRP 2 mg/l (0-5) * projekt CLL akcelerace 31/5/2023 posledn\u00ed odb\u011br po restartu terapie * sono b\u0159icha 14.9.2021 v\u00fdrazn\u00e1 splemomegalie, dilatovan\u00e1 lien\u00e1ln\u00ed \u017e\u00edla a port\u00e1ln\u00ed \u017e\u00edla, 14x7cm, st.p. CHCE ledviny v norm\u011b meteorismus, j\u00e1tgran nezv\u011bt\u0161ena jemn\u011b zrnit\u00e9 struktury, bez lo\u017eiskov\u00fdch zm\u011bn * 12.4.23 sono b\u0159icha: j\u00e1tra nezvt\u0161en\u00e1, zrnit\u00e9 struktury, bez lo\u017eiskov\u00fdch zm\u011bn, st.p. CHCE v portae p\u0159etrvf\u00e1v\u00e1 dialtovan\u00e1 17mm, lewin\u00e1ln\u00ed \u017e\u00edla 14-17mm slezina 197x67x48mm, ojedin\u011bl\u00e9 kalcifikace zrnit\u00e1 struktura ledviny v norm\u011b, septovan\u00e1 korov\u00e1 cysta 51mm vlevo, progrese velikosti od minule, bez lithi\u00e1zy 16.8.2023 sono b\u0159icha: j\u00e1tra norm\u00e1ln \u00edvelioti a norm\u00e1ln \u00edechogenity, bez lo\u017eiskov\u00fdch ztm\u011bn, intrahepatick\u00e9 \u017elu\u010dovody nejosu dilatovgn,m jatenr\u00ed \u017e\u00edly bez dilatace, pankreas homogenn\u00ed,bez lo\u017eiskov\u00fdch z\u011bmn, bez dilatace duktu, salezina 18x5,3cm, splenomegalie, septovan\u00e1 cysta lev\u00e9 ledviny,k dilatace port\u00e1ln\u00ed a lien\u00e1ln\u00ed \u017e\u00edly, bez progrese, st.p. CHCE subj c\u00edt\u00ed se dob\u0159e nem\u00e1 krv\u00e1cen\u00ed, nem\u00e1 B symptomy obj: ECOG 0, 72kg ob\u011bhov\u011b komp, b\u0159icho m\u011bkk\u00e9 j\u00e1tra nezv\u011bt\u0161ena, slezina +5cm pod oblouk dlouhodob b\u0159icho je m\u011bkk\u00e9, bez rezistence, bez ascitu dkk bez otok\u016f Lu p\u0159ed k\u00fdva\u010dem vlevo 2x2cm, jinak nehmat\u00e1m ve v\u0161ech lokalizac\u00edch Dg Chronick\u00e1 lymfatick\u00e1 leuk\u00e9mie, datum dg nen\u00ed uvedeno, 1.7.21 poprv\u00e9 na IHOK, vstupn\u00ed stadium neuvedeno - p\u0159ed 30 lety terapie kortikoidy a leukeran 1990? DR Peprla sledoval r\u016fzn\u011b - mutovan\u00fd IgVGH, v\u00fdrazn\u00e1 splenoemgalie k pupku, Rai IV A - paraprotein\u00e9mie Ig G kappa, stabiln\u00ed 6g/l, hypogamaglobulin\u00e9mie IgM, IgA - sonografie 16.12.2020 22x12x8 cm velikost sleziny - 1.7.21 : mutace p53, mut IGHVodb\u011br prognostick\u00fdch fakotr\u016f n\u00edzce komplexn\u00ed karyotyp - pacientka napl\u0148uje krit\u00e9ria S\u00daKL zah\u00e1jen\u00ed l\u00e9\u010dby BCR inhibitorem - imbruvica start dne 12/8/2021 v 1. linii l\u00e9\u010dby - 26.8.2021 progrese trombocytopenie zat\u00edm pokra\u010duje Imbruvica stejn\u011b - dosa\u017eeno parci\u00e1ln\u00ed remise - 23.6..22 parci\u00e1ln\u00ed remise, Rai IVA, vysok\u00e9 riziko nemoci, nad\u00e1le lehk\u00e1 tromobcytopenie nov\u011b m\u00edrn\u00e1 neutropenie - imbruvica pora\u010duje stejn\u011b - p\u0159i progresi neutropenie SP k vyolu\u010den\u00ed MDS - 28.7.22 parci\u00e1ln\u00ed remise, pokra\u010dujeme Rai IA - p\u0159eru\u0161ena imbruvica 31.8.22 pro frakturu tibie, 19.9.22 nen \u00edprogrese Rai OA, - 24.10.22 p\u0159eru\u0161ena imbruvica sejmut\u00ed ort\u00e9zy 25.10. dle v\u00fdsledku RTG - 7.11.2022 Rai OA, indikov\u00e1no restart imbruvica - parci\u00e1ln\u00ed remise, 27.3.2023 Rai OA, terapie imbruvica - p\u0159eru\u0161ena imbruvica pro pl\u00e1n extrakce zub\u016f od 27.4.23 kontrola po extrakci tento t\u00fdden 11.5.23, restart imbruvica od 17.5.23 - 6.9.23 trv\u00e1 parci\u00e1ln\u00ed remise, p\u0159\u010ded\u00e1v\u00e1m \u017e\u00e1danku na CT, pan \u00edse ojbedn\u00e1 v nemocnici Surgal Elevace AST nejasn\u00e9 eitologie 6.9.23 - 1.7.2021 serologiue hepatitid negativn\u00ed, CMV Ig G pzitivn\u00ed, Ig M negativn\u00ed - ke kontrole PL Zrnit\u00e1 struktura jater dle sonografie 12.4.23 a 27.4.23 - splenomegalie, nelze vylou\u010dit port\u00e1ln\u00ed hypertenzi diltace porty a lien\u00e1ln\u00ed \u017e\u00edly od r 2021 - jatern\u00ed cirhoza ? Porucha vyprazdnov\u00e1n\u00ed mo\u010dov\u00e9ho m\u011bch\u00fd\u0159e, septovan\u00e1 cysta lev\u00e9 ledviny s progres\u00ed velikosti, - saonograficky mo\u010dov\u00fd m\u011bch\u00fd\u00e1\u0159 pr\u00e1zdn\u00fd, urologick\u00e1 kontrola dr Kr\u00e1l\u00edk, Surgal, zpr\u00e1vu nem\u00e1, jewn sonografii Pseudohyperkal\u00e9mie - p\u0159i leukocyt\u00f3ze Chronick\u00e1 ren\u00e1ln\u00ed insuficience, kreatinin 92 GF 0,85 - t.\u010d. v norm\u011b Cysta lev\u00e9 ledviny dle sonografie, sledov\u00e1j\u00ed DM 2. typu na PAD, o\u010dek\u00e1v\u00e1na glykosurioe p\u0159i gliflozinu Hypertenze Alergie propolis Doporu\u010den\u00ed: Pros\u00edm praktick\u00e9ho l\u00e9ka\u0159e o kontroln\u00ed vy\u0161et\u0159ne\u00ed jatern\u00edch test\u016f, dnes elevace AST nejasn \u00e9etiolkogie, dle sonografie nelze vylou\u010dit jatern\u00ed cirhozu s prot\u00e1ln\u00ed hypertenz\u00ed D\u00e1le pros\u00edm o proveden\u00ed odb\u011br\u016f krve ( urea,kreatinin) p\u0159ed CT, d\u011bkuji Pan \u00edsi zajist\u00ed term\u00edn CT, \u017e\u00e1danku m\u00e1 u sebe Prenesa 4mg 1x, Vokanamet 50/1000mg 2x1 hematologick\u00e1 medikace: Imbruvica 140mg 3-0-0 - P\u0159i u\u017e\u00edv\u00e1n\u00ed Imbruvicy je nutn\u00e9 vynechat konzumaci grapefruit\u016f a t\u0159ezalky. - Imbruvica m\u016f\u017ee v\u00e9st k poru\u0161e funkce krevn\u00edch desti\u010dek, proto je nutn\u00e9 tento l\u00e9k p\u0159ed jak\u00fdmkoliv krv\u00e1civ\u00fdm v\u00fdkonem vysadit 5-7 p\u0159ed v\u00fdkonem a nasadit zp\u011bt do medikace 5-7 dn\u00ed po v\u00fdkonu - Nen\u00ed vhodn\u00e9 sou\u010dasn\u00e9 pod\u00e1v\u00e1n\u00ed antikoagula\u010dn\u00ed terapie warfarinem. Pokud je nutno nasadit LMWH/heparin nebo DOAC, terapie Imbruvicou se mus\u00ed p\u0159echodn\u011b p\u0159eru\u0161it a jej\u00ed op\u011btovn\u00e9 nasazen\u00ed je nutn\u00e9 zkonzultovat s na\u0161\u00edm centrem. - Imbruvica je metabolizov\u00e1na CYP3A4, p\u0159ed nasazen\u00edm l\u00e9k\u016f ovliv\u0148uj\u00edc\u00edch funkci tohoto enzymu je nutn\u00e1 konzultace s n\u00e1mi a event. \u00faprava d\u00e1vky Imbruvicy - makrolidy, ciprofloxacin, azolov\u00e1 antimykotika, n\u011bkter\u00e1 antivirotika, diltiazem, verapamil, amiodaron, n\u011bkter\u00e1 antiepileptika. - mezi nej\u010dast\u011bj\u0161\u00ed ne\u017e\u00e1douc\u00ed \u00fa\u010dinky imbruvicy pat\u0159\u00ed krv\u00e1civ\u00e9 komplikace, fibrilace s\u00edn\u00ed a pr\u016fjem - tyto pot\u00ed\u017ee vhodn\u00e9 s n\u00e1mi konzultovat dnes 1 balen \u00edimbruvica 140mg 90tbl Odb\u011bry: KO+diff+ret, ZBV, LD, CRP beta 2 mikrogloublin flow perifferie serologie hepatitid Pokud nebudou nov\u00e9 pot\u00ed\u017ee, pak kontrola u n\u00e1s v listopadu amb 8 a pot\u00e9 vy\u0161et\u0159en\u00ed u Dr. Brychtov\u00e9, 6. patro pavilon L, amb 13 Pros\u00edm praktick\u00e9ho l\u00e9ka\u0159e o proveden\u00ed odb\u011br\u016f krve ( urea,kreatinin) p\u0159ed CT, d\u011bkuji Dal\u0161\u00ed kontrola v 8 dne: 22.11.2023 12:00 ",
  },
  {
    confidence: ".092648711380462850373",
    ic_amb_zad: "26089027",
    ic_amb_karta: "6059137",
    ic_pac: "86335",
    dat_zad: "2023-03-27",
    cas_zad: "14:03:00",
    prac_od: "41742",
    dg_kod: "",
    i_dg_kod: "C911 ",
    text_dg: "",
    i_text_dg: "Chronick\u00e1 lymfocytick\u00e1 leukemie z B-bun\u011bk ",
    poz_text: "",
    amb_zaz_text:
      "Odb\u011br:27.03.2023 12:15 ------------------------------------------------------------ Ret% 1.60 % Reta 68.00 10^9/l IRF 0.063 RET-He 33.6 pg WBC 16.490 10^9/l RBC 4.25 10^12/l HGB 126.0 g/l HCT 0.380 l/l MCV 89.9 fL PLT 103.0 10^9/l MCH 29.6 pg MCHC 330.0 g/l MPV 10.30 fl RDW 13.3 % NEU% 20.90 % LYM% 76.30 % MON% 2.20 % EOS% 0.40 % BAS% 0.20 % NEU 3.440 10^9/l LYM 12.590 10^9/l MONO 0.360 10^9/l EOS 0.060 10^9/l BASO 0.040 10^9/l NRBC 0.01 Odb\u011br:27.03.2023 12:15 Urea S-Urea 7.2 mmol/l (2.8-8.1) Kreat. S-Kreatinin 86 umol/l (44-80) CKD-EPI CKD-EPI Krea 0.91 ml/s/1.73m2 (1-2.4) KM S-Kys.mo\u010dov\u00e1 291 umol/l (143-339) Na S-Na 139 mmol/l (136-145) K S-K 4.1 mmol/l (3.5-5.1) Cl S-Cl 106 mmol/l (98-107) Bi-celk. S-Bilirubin celk 6.2 umol/l (2-21) ALT S-ALT 0.27 ukat/l (0.25-0.58) AST S-AST 0.31 ukat/l (0.17-0.6) GGT S-GMT 0.14 ukat/l (0.1-0.7) ALP S-ALP 0.79 ukat/l (0.58-1.74) Gluk\u00f3za S-Glukosa 6.9 mmol/l (3.9-5.6) CRP S-CRP 1.9 mg/l (0-5) sono b\u0159icha 14.9.2021 v\u00fdrzan\u00e1 sploegalie, dialtovan\u00e1 lein\u00e1ln\u00ed \u017e\u00edla a por\u00e1tln\u00ed \u017e\u00edla, 14x7cm, st.p. CHCE ledviny v norm\u011b meteorismus, j\u00e1tgran ezvt\u0161ena jemn\u011b zrnit\u00e9 struktury, bez lo\u017eiskov\u00fdch zm\u011bn subj pan\u00ed m\u00e1 novou l\u00e9ka\u0159ku na dibaetologii, m\u00e1 vel\u016fk\u00e9 b\u0159icho pan \u00ed\u00e9se zd\u00e1 setejn\u00e9, ale nehubne, chut k j\u00edlu m\u00e1 dobnrou nen\u00ed zhor\u0161ne\u00ed \u00fanavy nen \u00edpocje\u0161n\u00ed nejsou B smyptomy bere lah\u016fdkov\u00e9 kvasnice, d\u00e1le hl\u00edvu \u00fast\u0159i\u010dnou obj ECOG 0, 72kg obh\u011bov\u011b komp bez hmatn\u00e9 lymfadenopatie, j\u00e1tra nezv\u011bt\u0161ena, slezina nen\u00ed hmatni, b\u0159icho je m\u011bkk\u00e9, bez rezistence, bez ascitu dkk bez otok\u016f Dg Chronick\u00e1 lymfatick\u00e1 leuk\u00e9nie, datum dg nen\u00ed uvedeno, dnes 1.7.21 poprv\u00e9 na IHOK - vstupn\u00ed stadium neuvdeno - p\u0159ed 30 lety terapie kortikoidy a leukeran 1990? DR Peprla sledoval - r\u016fzn\u011b - mutovan\u00fd IgVGH, v\u00fdrazn\u00e1 splenoemgalie k pupku, Rai IV A - parraprotein\u00e9mie Ig G kappa, stabiln\u00ed 6g/l, hypogamaglobulin\u00e9mie Ig M, Ig A - sonografie 16.12.2020 22x12x8 cm velikost sleziny - 1.7.21 : mutace p53, mut IGHVodb\u011br prognostick\u00fdch fakotr\u016f n\u00edzce komplexn\u00ed karyotyp - pacientka napl\u0148uje krit\u00e9ria S\u00daKL zah\u00e1jen\u00ed l\u00e9\u010dby BCR inhibitorem - imbruvica start dne 12/8/2021 v 1. linii l\u00e9\u010dby - 26.8.2021 progrese trombocytopenie zat\u00edm pokra\u010duje Imbruvica stejn\u011b - dosa\u017eeno parci\u00e1ln\u00ed remise - 23.6..22 parci\u00e1ln\u00ed remise, Rai IVA, vysok\u00e9 riziko nemoci, nad\u00e1le lehk\u00e1 tromobcytopenie nov\u011b m\u00edrn\u00e1 neutropenie - imbruvica pora\u010duje stejn\u011b - p\u0159i progresi neutropenie SP k vyolu\u010den\u00ed MDS - 28.7.22 parci\u00e1ln\u00ed remise, pokra\u010dujeme Rai IA - p\u0159eru\u0161ena imbruvica 31.8.22 pro frakturu tibie, 19.9.22 nen \u00edprogrese Rai OA, - 24.10.22 p\u0159eru\u0161ena imbruvic,a sejmut\u00ed ort\u00e9zy 25.10. dle v\u00fdsledku RTG - 7.11.2022 Rai OA, indikov\u00e1no restart imbruvica - paric\u00e1ln \u00edremise, 27.3.2023 Rai OA, pporkaou\u010dje terapie Pseudohyperkal\u00e9mie - p\u0159i leukocyt\u00f3ze Chronick\u00e1 ren\u00e1ln\u00ed insuficience, kreatinin 92 GF 0,85 Cysta lev\u00e9 ledviny dle sonografie, sledov\u00e1j\u00ed DM 2. typu na PAD, o\u010dek\u00e1v\u00e1na glykosurioe p\u0159i gliflozinu Hypertenze Alergie propolis Doporu\u010den\u00ed: mediakce dlouhodob\u011b Prenesa 4mg 1x, Vokanamet 50/1000mg 2x1 hematologick\u00e1 medikace: Imbruvica 140mg 3-0-0, zap\u00edt min. 200ml vody od 8.11.22 - P\u0159i u\u017e\u00edv\u00e1n\u00ed Imbruvicy je nutn\u00e9 vynechat konzumaci grapefruit\u016f a t\u0159ezalky. - Imbruvica m\u016f\u017ee v\u00e9st k poru\u0161e funkce krevn\u00edch desti\u010dek, proto je nutn\u00e9 tento l\u00e9k p\u0159ed jak\u00fdmkoliv krv\u00e1civ\u00fdm v\u00fdkonem vysadit 5-7 p\u0159ed v\u00fdkonem a nasadit zp\u011bt do medikace 5-7 dn\u00ed po v\u00fdkonu - Nen\u00ed vhodn\u00e9 sou\u010dasn\u00e9 pod\u00e1v\u00e1n\u00ed antikoagula\u010dn\u00ed terapie warfarinem. Pokud je nutno nasadit LMWH/heparin nebo DOAC, terapie Imbruvicou se mus\u00ed p\u0159echodn\u011b p\u0159eru\u0161it a jej\u00ed op\u011btovn\u00e9 nasazen\u00ed je nutn\u00e9 zkonzultovat s na\u0161\u00edm centrem. - Imbruvica je metabolizov\u00e1na CYP3A4, p\u0159ed nasazen\u00edm l\u00e9k\u016f ovliv\u0148uj\u00edc\u00edch funkci tohoto enzymu je nutn\u00e1 konzultace s n\u00e1mi a event. \u00faprava d\u00e1vky Imbruvicy - makrolidy, ciprofloxacin, azolov\u00e1 antimykotika, n\u011bkter\u00e1 antivirotika, diltiazem, verapamil, amiodaron, n\u011bkter\u00e1 antiepileptika. - mezi nej\u010dast\u011bj\u0161\u00ed ne\u017e\u00e1douc\u00ed \u00fa\u010dinky imbruvicy pat\u0159\u00ed krv\u00e1civ\u00e9 komplikace, fibrilace s\u00edn\u00ed a pr\u016fjem - tyto pot\u00ed\u017ee vhodn\u00e9 s n\u00e1mi konzultovat ---------------------------------------------------------------- p\u0159e\u00e1dv\u00e1 m\u017e\u00e1dnak una sonografii b\u0159icha, apn \u00edse ojbedn\u00e1 v Surgal clinic Na\u0161e kontropal p\u0159i zhro\u0161en\u00ed stavu nebo za 3 m\u011bs\u00edce Imbruvica 90tbl 140mg III balen\u00ed Tel. na na\u0161\u00ed amb. 53223 3562 dnes 3 balen\u00ed imbruvica Odb\u011bry: KO+dif., rtc., ZBV, ionty statim do nestatim zkumavky beta 2 mikrogloublin Dal\u0161\u00ed kontrola v 4 dne: 05.06.2023 11:00 ",
  },
  {
    confidence: ".089370029007298082412",
    ic_amb_zad: "26558076",
    ic_amb_karta: "6059137",
    ic_pac: "86335",
    dat_zad: "2023-04-26",
    cas_zad: "14:40:00",
    prac_od: "41742",
    dg_kod: "",
    i_dg_kod: "C911 ",
    text_dg: "",
    i_text_dg: "Chronick\u00e1 lymfocytick\u00e1 leukemie z B-bun\u011bk ",
    poz_text: "",
    amb_zaz_text:
      'Odb\u011br:26.04.2023 11:57 ------------------------------------------------------------ WBC 18.700 10^9/l RBC 4.81 10^12/l HGB 141.0 g/l HCT 0.430 l/l MCV 89.9 fL PLT 120.0 10^9/l MCH 29.2 pg MCHC 325.0 g/l MPV 11.40 fl RDW 13.9 % NEU% 20.50 % LYM% 77.30 % MON% 2.05 % EOS% 0.09 % BAS% 0.12 % NEU 3.831 10^9/l LYM 14.400 10^9/l MONO 0.384 10^9/l EOS 0.017 10^9/l BASO 0.023 10^9/l NRBC 0.00 10^9/l NRBC/WBC 0.00 /100WBC Neu mikr 18.0 % Ty\u010d mikr 0.0 % Lym mikr 81.0 % Mon mikr 0.0 % Eos mikr 0.0 % Bas mikr 1.0 % META mik 0.0 % MYEL mik 0.0 % PROM mik 0.0 % Mybl mik 0.0 % Prol mik 0.0 % Plb mikr 0.0 % Nedif.bb 0.0 % Nedif.bl 0.0 % NRBC-Mik 0.0 /100 bb LGL 0.561 10^9/l MorfoLEU : MorfoLEU MorfoERY : MorfoPLT oj. hypogranulace PLT, Hodnotil Sedl\u00e1\u0159ov\u00e1 Sabina Mgr. Hl\u00e1\u0161Anal Variant lymph. susp. Pozn\u00e1mka : dnes odb\u011br vzroku CLL akceleerace sono b\u0159icha 14.9.2021 v\u00fdrzan\u00e1 sploegalie, dialtovan\u00e1 lein\u00e1ln\u00ed \u017e\u00edla a por\u00e1tln\u00ed \u017e\u00edla, 14x7cm, st.p. CHCE ledviny v norm\u011b meteorismus, j\u00e1tgran ezvt\u0161ena jemn\u011b zrnit\u00e9 struktury, bez lo\u017eiskov\u00fdch zm\u011bn 12.4.23 sono b\u0159icha: j\u00e1tra nezvt\u0161en\u00e1, zrnit\u00e9 struktury, bez lo\u017eiskov\u00fdch zm\u011bn, sdt.p. CHCE v portae p\u0159etrvf\u00e1v\u00e1 dialtovan\u00e1 17mm, lewin\u00e1ln\u00ed \u017e\u00edla 14-17mm salezina 197x67x48mm, ojedin\u011bl\u00e9 kalcifikace zrnit\u00e1 struktura ledviny v norm\u011b, septovan\u00e1 korov\u00e1\u00fd cysta 51mm vlevo, progrese velikosti od minule , bez lithi\u00ed\u00e1zy subj pl\u00e1n trh\u00e1n\u00ed zub\u016f, na gynekolgoii zji\u0161t\u011bno p\u0159etrv\u00e1v\u00e1n\u00ed\u00e1 mo\u010di v mo\u010do\u00e9vm m\u011bch\u00e1\u0159i, je objedn\u00e1na proto na urologii jde z\u00edtra nem\u00e1 krv\u00e1cen\u00ed nem\u00e1 B symptomy obj: ECOG 0 , 72kg obh\u011bov\u011b komp bez hmatn\u00e9 lymfadenopatie, j\u00e1tra nezv\u011bt\u0161ena, slezina nen\u00ed hmatni, b\u0159icho je m\u011bkk\u00e9, bez rezistence, bez ascitu dkk bez otok\u016f Dg Porucha vyprazdnov\u00e1n\u00ed mo\u010do\u00e9ho m\u011bch\u00fd\u0159e, pl\u00e1n urogloick\u00e9 ho vy\u0161et\u0159en\u00ed Cysta lev\u00e9 ledviny, progreduj\u00edc\u00ed dle osnografie - konzultace urologa Pl\u00e1n extrakce zub\u016fp 5.56.23 - p\u0159eru\u0161ena imbruvica Chronick\u00e1 lymfatick\u00e1 leuk\u00e9nie, datum dg nen\u00ed uvedeno, dnes 1.7.21 poprv\u00e9 na IHOK - vstupn\u00ed stadium neuvdeno - p\u0159ed 30 lety terapie kortikoidy a leukeran 1990? DR Peprla sledoval - r\u016fzn\u011b - mutovan\u00fd IgVGH, v\u00fdrazn\u00e1 splenoemgalie k pupku, Rai IV A - parraprotein\u00e9mie Ig G kappa, stabiln\u00ed 6g/l, hypogamaglobulin\u00e9mie Ig M, Ig A - sonografie 16.12.2020 22x12x8 cm velikost sleziny - 1.7.21 : mutace p53, mut IGHVodb\u011br prognostick\u00fdch fakotr\u016f n\u00edzce komplexn\u00ed karyotyp - pacientka napl\u0148uje krit\u00e9ria S\u00daKL zah\u00e1jen\u00ed l\u00e9\u010dby BCR inhibitorem - imbruvica start dne 12/8/2021 v 1. linii l\u00e9\u010dby - 26.8.2021 progrese trombocytopenie zat\u00edm pokra\u010duje Imbruvica stejn\u011b - dosa\u017eeno parci\u00e1ln\u00ed remise - 23.6..22 parci\u00e1ln\u00ed remise, Rai IVA, vysok\u00e9 riziko nemoci, nad\u00e1le lehk\u00e1 tromobcytopenie nov\u011b m\u00edrn\u00e1 neutropenie - imbruvica pora\u010duje stejn\u011b - p\u0159i progresi neutropenie SP k vyolu\u010den\u00ed MDS - 28.7.22 parci\u00e1ln\u00ed remise, pokra\u010dujeme Rai IA - p\u0159eru\u0161ena imbruvica 31.8.22 pro frakturu tibie, 19.9.22 nen \u00edprogrese Rai OA, - 24.10.22 p\u0159eru\u0161ena imbruvic,a sejmut\u00ed ort\u00e9zy 25.10. dle v\u00fdsledku RTG - 7.11.2022 Rai OA, indikov\u00e1no restart imbruvica - parci\u00e1ln\u00ed remise, 27.3.2023 Rai OA, terapie imbruvica dle sonografie 12.4.23 splneomgalie, nelze vylou\u010dit por\u00e1tln\u00ed hypertenzi diltace porty a lien\u00e1ln\u00ed \u017e\u00edly od r 2021 Pseudohyperkal\u00e9mie - p\u0159i leukocyt\u00f3ze Chronick\u00e1 ren\u00e1ln\u00ed insuficience, kreatinin 92 GF 0,85 Cysta lev\u00e9 ledviny dle sonografie, sledov\u00e1j\u00ed DM 2. typu na PAD, o\u010dek\u00e1v\u00e1na glykosurioe p\u0159i gliflozinu Hypertenze Alergie propolis Doporu\u010den\u00ed: exktrace zub\u016f bez hematolglick\u00e9 p\u0159\u00edpra,vy pouze p\u0159eru\u0161en\u00ed medikace imbruvica d\u00e1le dle pr\u016fb\u011bhu extrakce domluva o znovu nasazen\u00ed medikace mediakce dlouhodob\u011b Prenesa 4mg 1x, Vokanamet 50/1000mg 2x1 hematologick\u00e1 medikace: Imbruvica 140mg 3-0-0, zap\u00edt min. 200ml vody od 8.11.22 dnes naposledy, od z\u00edt\u0159ka nebrat, pol\u016f\u00e1n exrakce zub\u016f - P\u0159i u\u017e\u00edv\u00e1n\u00ed Imbruvicy je nutn\u00e9 vynechat konzumaci grapefruit\u016f a t\u0159ezalky. - Imbruvica m\u016f\u017ee v\u00e9st k poru\u0161e funkce krevn\u00edch desti\u010dek, proto je nutn\u00e9 tento l\u00e9k p\u0159ed jak\u00fdmkoliv krv\u00e1civ\u00fdm v\u00fdkonem vysadit 5-7 p\u0159ed v\u00fdkonem a nasadit zp\u011bt do medikace 5-7 dn\u00ed po v\u00fdkonu - Nen\u00ed vhodn\u00e9 sou\u010dasn\u00e9 pod\u00e1v\u00e1n\u00ed antikoagula\u010dn\u00ed terapie warfarinem. Pokud je nutno nasadit LMWH/heparin nebo DOAC, terapie Imbruvicou se mus\u00ed p\u0159echodn\u011b p\u0159eru\u0161it a jej\u00ed op\u011btovn\u00e9 nasazen\u00ed je nutn\u00e9 zkonzultovat s na\u0161\u00edm centrem. - Imbruvica je metabolizov\u00e1na CYP3A4, p\u0159ed nasazen\u00edm l\u00e9k\u016f ovliv\u0148uj\u00edc\u00edch funkci tohoto enzymu je nutn\u00e1 konzultace s n\u00e1mi a event. \u00faprava d\u00e1vky Imbruvicy - makrolidy, ciprofloxacin, azolov\u00e1 antimykotika, n\u011bkter\u00e1 antivirotika, diltiazem, verapamil, amiodaron, n\u011bkter\u00e1 antiepileptika. - mezi nej\u010dast\u011bj\u0161\u00ed ne\u017e\u00e1douc\u00ed \u00fa\u010dinky imbruvicy pat\u0159\u00ed krv\u00e1civ\u00e9 komplikace, fibrilace s\u00edn\u00ed a pr\u016fjem - tyto pot\u00ed\u017ee vhodn\u00e9 s n\u00e1mi konzultovat Tel. na na\u0161\u00ed amb. 53223 3562 Odb\u011bry: KO+diff na sklo ZBV, ionty statim do nestatim zkumavky beta 2 mikrogloublin odb\u011br "CLL akcelerace" , imbruvica p\u0159eru\u0161ena dne 27.4.23 - 5x5ml EDTA,m \u017e\u00e1danka mol genetika CLL akcelerace + KO diff na sklo ( viz rozpis projektu dr Panovsk\u00e1) dal\u0161\u00ed odb\u011bry po nasazen\u00ed medikace za 2 t\u00fddny a domluva s l\u00e9ka\u0159em o znovunasazen\u00ed imbruvica s zpr\u00e1vou od urologa p\u0159ed\u00e1v\u00e1m pan \u00edkopii osnografie b\u0159icha Dal\u0161\u00ed kontrola v 4 dne: 09.05.2023 12:00 ',
  },
].map((record) => ({
  ...record,
  type: "Ambulatní zpráva",
}));

const descOptions = new Set(records.map((record) => record.text_dg))
  .values()
  .map((dg) => ({ uid: dg, name: dg.length == 0 ? "Prázdný" : capitalize(dg) }))
  .toArray();

export { columns, records, descOptions };
